A host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.
The AI Revolution That Could Slow Parkinson In Its Tracks
Paradigm Shift in Parkinson’s Disease Diagnosis
Extended Use of Investigational Agent IPX203 Safe in Parkinson Disease
Episode 108: Advancing the Genetic Pool of Parkinson Disease
NeurologyLive® Brain Games: April 14, 2024
NeurologyLive® Friday 5 — April 12, 2024